April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Leukemia patient finds donor halfway around the world
May 9, 2019 | Letisia Marquez
Acute myeloid leukemia patient Leif Voeltz's perfect match for a bone marrow transplant was located in Germany. Now Marcel Waldmann is traveling to the U.S. for the first time to meet the man whose life he saved.
City of hope's bone marrow transplant program reaches two historic milestones
February 26, 2019 | City of Hope
City of Hope’s bone marrow transplant has played a crucial role in the advancement of the procedure that it began doing more than four decades ago.
City of Hope doctor co-edits annual report highlighting cancer breakthroughs
January 31, 2019 | Michael Easterling
Sumanta K. Pal, M.D., was selected to serve as one of three editors of this year’s Clinical Cancer Advances, an annual report on the progress against cancer distributed by the American Society of Clinical Oncology.
Clinical research nurses: ‘Shepherds’ of the CAR T program
January 9, 2019 | Abe Rosenberg
What's it like to work at the center of a true medical and scientific revolution? It's emotional, often overwhelming. But it’s also a place to witness miracles. Such is the life of the clinical research nurses who staff City of Hope's CAR T cell program.
City of Hope investigators present breakthrough research at 60th American Society of Hematology meeting
December 5, 2018 | Letisia Marquez
Physicians and researchers at the 2018 American Society of Hematology conference presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative therapeutic approaches aimed at improving treatment options and quality of life for patients.
Groundbreaking new CAR T cell trial opens for patients with breast cancer that has spread to the brain
October 30, 2018 | Letisia Marquez
A new City of Hope chimeric antigen receptor (CAR) T cell trial – the first to focus on HER2-postive breast cancer patients with brain metastases – is now enrolling potential participants.
Parker Institute for Cancer Immunotherapy Welcomes Stephen J. Forman, M.D.
September 27, 2018 | Letisia Marquez
City of Hope’s Stephen J. Forman, M.D., is now an official member of the Parker Institute for Cancer Immunotherapy.